Bliss GVS Pharma Limited — Others, 09-07-2025: Shareholders meeting

Bliss GVS Pharma Limited has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025, along with the declaration of a final dividend of 50% (₹0.50 per share). The company has fixed the record date for the dividend entitlement and will make payments subject to tax deductions. Shareholders will vote on the re-appointment of Dr. Vibha Gagan Sharma as a director liable to retire by rotation. Additionally, M/s. AVS & Associates has been proposed for appointment as Secretarial Auditors for five consecutive years starting FY 2025-26, ensuring continued compliance and governance oversight.